NewGenIvf Group Limited (NIVF)

NewGenIvf Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	5.43	5.14	5.94	4.12
Revenue Growth (YoY)	5.79%	-13.59%	44.34%	-
Cost of Revenue	3.61	3.45	4.41	3.09
Gross Profit	1.83	1.68	1.54	1.02
Selling, General & Admin	2.99	1.64	1.14	0.83
Operating Expenses	2.99	1.64	1.14	0.83
Operating Income	-1.16	0.04	0.4	0.2
Interest Expense	-0.78	-0.05	-0.08	-0.09
Interest & Investment Income	0.01	0	0	0
Other Non Operating Income (Expenses)	0.97	0.11	0.02	0.05
Pretax Income	-0.96	0.11	0.34	0.16
Income Tax Expense	-0.49	-	0.21	0.29
Earnings From Continuing Operations	-0.47	0.11	0.14	-0.14
Minority Interest in Earnings	-0.05	0.02	0.32	0.14
Net Income	-0.52	0.13	0.46	-0
Net Income to Common	-0.52	0.13	0.46	-0
Net Income Growth	-	-71.61%	-	-
Free Cash Flow	-8.32	-1.84	1.62	1.42
Gross Margin	33.62%	32.74%	25.87%	24.88%
Operating Margin	-21.36%	0.82%	6.71%	4.83%
Profit Margin	-9.66%	2.54%	7.72%	-0.01%
Free Cash Flow Margin	-153.08%	-35.75%	27.19%	34.39%
EBITDA	-1.14	0.07	0.5	0.37
EBITDA Margin	-21.00%	1.43%	8.40%	8.88%
D&A For EBITDA	0.02	0.03	0.1	0.17
EBIT	-1.16	0.04	0.4	0.2
EBIT Margin	-21.36%	0.82%	6.71%	4.83%
Effective Tax Rate	-	-	60.51%	188.70%

Updated Dec 5, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q